Demineralized Bone Matrix (DBM) Market Growth, Trends, and Forecast 2032

The global demineralized bone matrix (DBM) market is projected to grow from $1.18 billion in 2024 to $1.94 billion by 2032, with a 6.4% CAGR. North America leads with 45.05% market share, driven by major companies like Medtronic, Johnson & Johnson, and Zimmer Biomet. Key market segments include: Product types: Gel, putty, and others Applications: Dental, spinal fusion, joint reconstruction, long bone procedures End users: Hospitals, specialty clinics Recent developments show market expansion: January 2023: Orthofix Medical merged with SeaSpine to enhance biologics portfolio June 2022: AlloSource launched AlloFuse microfibers for spinal procedures June 2022: Stryker opened new R&D facility in Gurgaon, India Market growth is driven by rising orthopedic disorders (1.71 billion people globally affected) and aging populations, with osteoporosis causing over 8.9 million fractures annually. However, high costs remain a constraint, particularly in emerging economies where dental bone grafts can cost $400-$1,200 per procedure. Rising orthopedic disorders (1.71 billion people globally affected by musculoskeletal conditions) Increasing spinal fusion surgeries Growing dental procedures (3.5 billion people affected by oral diseases) Report- Fortune Business Insights - Demineralized Bone Matrix Market Size & Share, 2032 https://www.fortunebusinessinsights.com/demineralized-bone-matrix-dbm-market-105449